WhitTier Trust Company’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.67K | Sell |
11
-275
| -96% | -$41.7K | ﹤0.01% | 1328 |
|
|
2025
Q1 | $43K | Hold |
286
| – | – | ﹤0.01% | 813 |
|
|
2024
Q4 | $52.8K | Buy |
286
+7
| +3% | +$1.29K | ﹤0.01% | 744 |
|
|
2024
Q3 | $55K | Sell |
279
-2
| -0.7% | -$394 | ﹤0.01% | 728 |
|
|
2024
Q2 | $58K | Buy |
281
+193
| +219% | +$39.9K | ﹤0.01% | 670 |
|
|
2024
Q1 | $23.8K | Hold |
88
| – | – | ﹤0.01% | 829 |
|
|
2023
Q4 | $20.8K | Sell |
88
-12
| -12% | -$2.84K | ﹤0.01% | 832 |
|
|
2023
Q3 | $19.6K | Sell |
100
-152
| -60% | -$29.8K | ﹤0.01% | 817 |
|
|
2023
Q2 | $53K | Buy |
252
+5
| +2% | +$1.05K | ﹤0.01% | 658 |
|
|
2023
Q1 | $49.8K | Hold |
247
| – | – | ﹤0.01% | 663 |
|
|
2022
Q4 | $53.8K | Sell |
247
-8,901
| -97% | -$1.94M | ﹤0.01% | 655 |
|
|
2022
Q3 | $1.8M | Buy |
9,148
+613
| +7% | +$121K | 0.08% | 208 |
|
|
2022
Q2 | $1.83M | Buy |
8,535
+602
| +8% | +$129K | 0.08% | 211 |
|
|
2022
Q1 | $2.25M | Buy |
7,933
+1,934
| +32% | +$549K | 0.08% | 196 |
|
|
2021
Q4 | $2.26M | Buy |
5,999
+664
| +12% | +$250K | 0.08% | 191 |
|
|
2021
Q3 | $2.2M | Buy |
5,335
+235
| +5% | +$97K | 0.09% | 189 |
|
|
2021
Q2 | $1.89M | Buy |
5,100
+113
| +2% | +$41.8K | 0.08% | 198 |
|
|
2021
Q1 | $1.45M | Buy |
4,987
+503
| +11% | +$146K | 0.06% | 215 |
|
|
2020
Q4 | $1.12M | Buy |
4,484
+410
| +10% | +$102K | 0.06% | 229 |
|
|
2020
Q3 | $923K | Buy |
+4,074
| New | +$923K | 0.05% | 232 |
|